Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Abciximab treatment validated for prevention of ischemic complications after coronary intervention

July 9, 1998

Cor Therapeutics describes selective factor Xa inhibitors

July 8, 1998

Platelet aggregation inhibitors in development at Meiji Seika

July 6, 1998

FDA advisory committee to review Pletal NDA next week

July 3, 1998

Zeria discloses new thromboxane antagonists for thrombosis

July 3, 1998

HMR introduces Refludan in U.S.

July 2, 1998

Factor Xa inhibitors developed by Boehringer Mannheim researchers

June 30, 1998

RPR acquires worldwide rights to Novartis anticoagulant

June 29, 1998

Schering-Plough initiates phase I with oral antithrombotic

June 25, 1998

BioChem Pharma describes lactams for thrombotic disorders

June 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...